215 related articles for article (PubMed ID: 8847893)
1. Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts.
Stacchini A; Fubini L; Severino A; Sanavio F; Aglietta M; Piacibello W
Leukemia; 1996 Oct; 10(10):1584-91. PubMed ID: 8847893
[TBL] [Abstract][Full Text] [Related]
2. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
3. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
Tafuri A; De Felice L; Mascolo MG; Valentini T; Petrucci MT; Petti MC
Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
[TBL] [Abstract][Full Text] [Related]
4. Primary acute myeloid leukemia cells negative for c-kit receptor protein expression do not proliferate in vitro in response to colony-stimulating factors.
Hirakawa K; Kimura S; Chikayama S; Misawa S; Maekawa T
Leukemia; 1996 Feb; 10(2):279-87. PubMed ID: 8637237
[TBL] [Abstract][Full Text] [Related]
5. Differential response to stem cell factor and Flt3 ligand by the FAB subtype in acute myeloid leukemia clonogenic cells.
Murohashi I; Yoshida K; Kishimoto K; Takahashi T; Wakao D; Jinnai I; Yagasaki F; Kawai N; Suzuki T; Matsuda A; Hirashima K; Bessho M
J Interferon Cytokine Res; 2002 Mar; 22(3):335-41. PubMed ID: 12034041
[TBL] [Abstract][Full Text] [Related]
6. Expression of the flt3 receptor and its ligand on hematopoietic cells.
Brasel K; Escobar S; Anderberg R; de Vries P; Gruss HJ; Lyman SD
Leukemia; 1995 Jul; 9(7):1212-8. PubMed ID: 7630197
[TBL] [Abstract][Full Text] [Related]
7. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax.
Lisovsky M; Estrov Z; Zhang X; Consoli U; Sanchez-Williams G; Snell V; Munker R; Goodacre A; Savchenko V; Andreeff M
Blood; 1996 Nov; 88(10):3987-97. PubMed ID: 8916965
[TBL] [Abstract][Full Text] [Related]
8. Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines.
Meierhoff G; Dehmel U; Gruss HJ; Rosnet O; Birnbaum D; Quentmeier H; Dirks W; Drexler HG
Leukemia; 1995 Aug; 9(8):1368-72. PubMed ID: 7643626
[TBL] [Abstract][Full Text] [Related]
9. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
[TBL] [Abstract][Full Text] [Related]
10. The effects of human FLT3 ligand on in vitro human megakaryocytopoiesis.
Piacibello W; Garetto L; Sanavio F; Severino A; Fubini L; Stacchini A; Dragonetti G; Aglietta M
Exp Hematol; 1996 Feb; 24(2):340-6. PubMed ID: 8641363
[TBL] [Abstract][Full Text] [Related]
11. Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells.
Dehmel U; Zaborski M; Meierhoff G; Rosnet O; Birnbaum D; Ludwig WD; Quentmeier H; Drexler HG
Leukemia; 1996 Feb; 10(2):261-70. PubMed ID: 8637235
[TBL] [Abstract][Full Text] [Related]
12. The c-kit molecule and the surface immunophenotype of human acute leukemia.
Kubota A; Okamura S; Shimoda K; Harada M; Niho Y
Leuk Lymphoma; 1994 Aug; 14(5-6):421-8. PubMed ID: 7529077
[TBL] [Abstract][Full Text] [Related]
13. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.
Veiby OP; Jacobsen FW; Cui L; Lyman SD; Jacobsen SE
J Immunol; 1996 Oct; 157(7):2953-60. PubMed ID: 8816402
[TBL] [Abstract][Full Text] [Related]
14. Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells.
Rosnet O; Bühring HJ; Marchetto S; Rappold I; Lavagna C; Sainty D; Arnoulet C; Chabannon C; Kanz L; Hannum C; Birnbaum D
Leukemia; 1996 Feb; 10(2):238-48. PubMed ID: 8637232
[TBL] [Abstract][Full Text] [Related]
15. Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells.
Spiekermann K; Bagrintseva K; Schwab R; Schmieja K; Hiddemann W
Clin Cancer Res; 2003 Jun; 9(6):2140-50. PubMed ID: 12796379
[TBL] [Abstract][Full Text] [Related]
16. Effects of flt3 ligand on acute myeloid and lymphocytic leukemic blast cells from children.
McKenna HJ; Smith FO; Brasel K; Hirschstein D; Bernstein ID; Williams DE; Lyman SD
Exp Hematol; 1996 Feb; 24(2):378-85. PubMed ID: 8641369
[TBL] [Abstract][Full Text] [Related]
17. Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects the growth in culture of the blast cells of acute myeloblastic leukemia.
Wang C; Koistinen P; Yang GS; Williams DE; Lyman SD; Minden MD; McCulloch EA
Leukemia; 1991 Jun; 5(6):493-9. PubMed ID: 1711640
[TBL] [Abstract][Full Text] [Related]
18. Identification of CD19(-)B220(+)c-Kit(+)Flt3/Flk-2(+)cells as early B lymphoid precursors before pre-B-I cells in juvenile mouse bone marrow.
Ogawa M; ten Boekel E; Melchers F
Int Immunol; 2000 Mar; 12(3):313-24. PubMed ID: 10700466
[TBL] [Abstract][Full Text] [Related]
19. Src family tyrosine kinases are activated by Flt3 and are involved in the proliferative effects of leukemia-associated Flt3 mutations.
Robinson LJ; Xue J; Corey SJ
Exp Hematol; 2005 Apr; 33(4):469-79. PubMed ID: 15781338
[TBL] [Abstract][Full Text] [Related]
20. Effects of FLT3 ligand on human leukemia cells. II. Agonistic and antagonistic effects of other cytokines.
Dehmel U; Quentmeier H; Drexler HG
Leukemia; 1996 Feb; 10(2):271-8. PubMed ID: 8637236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
